Brand-Name Drug

A brand-name drug is the version of a medication sold by the company that originally developed it, under a trademarked name and while patent protection is still in force. The patent typically runs 20 years from filing, though the effective market exclusivity is usually 10 to 14 years after FDA approval. During that window, the brand is the only source and prices reflect that.

Brand-name drugs sit on Tier 2 (preferred) or Tier 3 (non-preferred) of most formularies, with copays running $40 to $150 or coinsurance of 20 to 40 percent. The distinction between preferred and non-preferred is often about rebates the PBM negotiated with the manufacturer, not clinical merit. Manufacturer copay cards can cut member cost significantly on brands, though some plans use "copay accumulator" or "copay maximizer" programs to prevent the card value from counting toward the deductible — a controversial practice. Direct-to-consumer options like Mark Cuban's Cost Plus Drugs and manufacturer direct-purchase programs are quietly pulling brand pricing lower for cash-pay buyers.

The takeaway: if you're on a brand-name drug, check three prices — insurance copay, manufacturer copay card, and cash from a direct-purchase pharmacy. The lowest of the three is often not the insurance number.